​

Lexeo Therapeutics (LXEO) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

LXEO Stock Forecast

Lexeo Therapeutics (LXEO) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $20.00, with a high of $30.00 and a low of $13.00. This represents a 103.25% increase from the last price of $9.84.

$5 $10 $15 $20 $25 $30 High: $30 Avg: $20 Low: $13 Last Closed Price: $9.84

LXEO Stock Rating

Lexeo Therapeutics stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

LXEO Price Target Upside V Benchmarks

TypeNameUpside
StockLexeo Therapeutics103.25%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts555
Avg Price Target$19.00$19.00$19.00
Last Closing Price$9.84$9.84$9.84
Upside/Downside93.09%93.09%93.09%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2535---8
Sep, 2535---8
Aug, 2535---8
Jul, 2534---7
Jun, 2534---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 21, 2025H.C. Wainwright$13.00$9.2241.00%32.11%
Oct 15, 2025Guggenheim$30.00$8.50252.94%204.88%
Oct 07, 2025Chardan Capital$17.00$8.25106.06%72.76%
Oct 07, 2025H.C. Wainwright$15.00$8.2581.82%52.44%
Oct 07, 2025Mani ForooharLeerink Partners$20.00$8.25142.42%103.25%
Jun 12, 2024Brian SkorneyRobert W. Baird$28.00$18.1953.93%184.55%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 15, 2025GuggenheimBuyinitialise
Oct 07, 2025H.C. WainwrightBuyBuyhold
Jul 31, 2025OppenheimerOutperforminitialise
Jun 06, 2024H.C. WainwrightBuyinitialise
Mar 12, 2024RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

$-11 $-9 $-7 $-5 $-3 $-1 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.49$-3.09----
Avg Forecast$-6.66$-3.12$-3.01$-3.12$-3.56$-2.81
High Forecast$-3.95$-3.01$-1.94$-1.78$-3.56$-2.81
Low Forecast$-10.30$-3.29$-4.16$-4.63$-3.56$-2.81
Surprise %-62.61%-0.96%----

Revenue Forecast

$50M $110M $170M $230M $290M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$4.50M$1.13M-$57.00M$321.00M
High Forecast-$4.50M$1.13M-$57.00M$321.00M
Low Forecast-$4.50M$1.13M-$57.00M$321.00M
Surprise %------

Net Income Forecast

$-300M $-240M $-180M $-120M $-60M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-66.39M$-98.33M----
Avg Forecast$-189.88M$-86.60M$-104.22M$-89.22M$-94.73M$-74.88M
High Forecast$-105.25M$-80.23M$-51.61M$-47.45M$-94.73M$-74.88M
Low Forecast$-274.51M$-87.64M$-110.72M$-123.49M$-94.73M$-74.88M
Surprise %-65.03%13.55%----

LXEO Forecast FAQ

Is Lexeo Therapeutics stock a buy?

Lexeo Therapeutics stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Lexeo Therapeutics is a favorable investment for most analysts.

What is Lexeo Therapeutics's price target?

Lexeo Therapeutics's price target, set by 5 Wall Street analysts, averages $20 over the next 12 months. The price target range spans from $13 at the low end to $30 at the high end, suggesting a potential 103.25% change from the previous closing price of $9.84.

How does Lexeo Therapeutics stock forecast compare to its benchmarks?

Lexeo Therapeutics's stock forecast shows a 103.25% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Lexeo Therapeutics over the past three months?

  • October 2025: 37.50% Strong Buy, 62.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 37.50% Strong Buy, 62.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 37.50% Strong Buy, 62.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Lexeo Therapeutics’s EPS forecast?

Lexeo Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-3.01, marking a -2.59% decrease from the reported $-3.09 in 2024. Estimates for the following years are $-3.12 in 2026, $-3.56 in 2027, and $-2.81 in 2028.

What is Lexeo Therapeutics’s revenue forecast?

Lexeo Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $1.12M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $57M for 2027, and $321M for 2028.

What is Lexeo Therapeutics’s net income forecast?

Lexeo Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-104M, representing an 5.98% increase from the reported $-98.333M in 2024. Projections indicate $-89.223M in 2026, $-94.728M in 2027, and $-74.876M in 2028.